Insider trade

Impact Biomedical (IBO): 10% owner sold ~$560

DSS, 10% owner at Impact Biomedical, sold ~$560 of Impact Biomedical shares.

~$560
Approx. value · 200 sh @ $2.80
58K
Holds after · shares reported
Traded
Nov 13, 2024
Filed
Nov 22, 2024

What stands out in this filing

  • The sale was 0.3% of the shares this insider held before it; the filing reports 58,100 shares, held indirectly afterwards.
  • 200 shares at an average of $2.80 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 12, 2024Insider10% owner sold ~$1.4K of IBO shares in the open market
  2. Nov 13, 2024 · this disclosureInsider10% owner sold ~$560 of IBO shares in the open market

What came next

  1. Nov 18, 2024Insider10% owner sold ~$15K of IBO shares in the open market
  2. Nov 26, 2024Insider · 1 personInsiders: 2 purchases (~$3K)
  3. Nov 27, 2024InsiderCEO purchased ~$1.3K of IBO shares in the open market
  4. Dec 5, 2024InsiderCEO purchased ~$1.1K of IBO shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Impact Biomedical

For Impact Biomedical, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IBO page.

Other recent filings by DSS, INC., 10% owner

The full history of DSS, INC., 10% owner is on the profile page.

How this filing works

Explore the data

Common questions

Which Impact Biomedical (IBO) insider traded, and how much?

DSS, 10% owner at Impact Biomedical, sold ~$560 of Impact Biomedical shares. 200 shares at $2.80.

When did it happen, and when was it made public?

Traded: Nov 13, 2024. Filed: Nov 22, 2024. That is 9 days between the two dates.

What stands out in this filing?

The sale was 0.3% of the shares this insider held before it; the filing reports 58,100 shares, held indirectly afterwards. 200 shares at an average of $2.80 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Impact Biomedical recently?

For Impact Biomedical, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the IBO page.

Does this mean IBO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Impact Biomedical

Everything OQRO holds on this company is on its IBO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data